{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:13:50Z","timestamp":1785176030076,"version":"3.55.0"},"reference-count":35,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The role of the gut in diabetes remission after Roux-en-Y gastric bypass (RYGB) is incompletely understood. We assessed the temporal change in insulin secretory capacity after RYGB, using oral and intravenous (IV) glucose, in individuals with type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Longitudinal, prospective measures of \u03b2-cell function were assessed after oral glucose intake and graded glucose infusion in individuals with severe obesity and diabetes studied at 0, 3 (n = 29), 12 (n = 24), and 24 (n = 20) months after RYGB. Data were collected between 2015 and 2019 in an academic clinical research center.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The decreases in body weight, fat mass, waist circumference, and insulin resistance after surgery (all P &amp;lt; 0.001 at 12 and 24 months) did not differ according to diabetes remission status. In contrast, both the magnitude and temporal changes in \u03b2-cell glucose sensitivity after oral glucose intake differed by remission status (P = 0.04): greater (6.5-fold; P &amp;lt; 0.01) and sustained in those in full remission, moderate and not sustained past 12 months in those with partial remission (3.3-fold; P &amp;lt; 0.001), and minimal in those not experiencing remission (2.7-fold; P = not significant). The improvement in \u03b2-cell function after IV glucose administration was not apparent until 12 months, significant only in those in full remission, and only \u223c33% of that observed after oral glucose intake. Preintervention \u03b2-cell function and its change after surgery predicted remission; weight loss and insulin sensitivity did not.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Our data show the time course of changes in \u03b2-cell function after RYGB. The improvement in \u03b2-cell function after RYGB, but not changes in weight loss or insulin sensitivity, drives diabetes remission.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc21-1270","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T18:06:04Z","timestamp":1638468364000},"page":"469-476","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":17,"title":["Role of the Gut in the Temporal Changes of \u03b2-Cell Function After Gastric Bypass in Individuals With and Without Diabetes Remission"],"prefix":"10.2337","volume":"45","clinical-trial-number":[{"clinical-trial-number":"nct02287285","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Malini","family":"Prasad","sequence":"first","affiliation":[{"name":"New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mark","sequence":"additional","affiliation":[{"name":"New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanel","family":"Ligon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Dutia","sequence":"additional","affiliation":[{"name":"New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Nair","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8255-3175","authenticated-orcid":false,"given":"Blandine","family":"Laferr\u00e8re","sequence":"additional","affiliation":[{"name":"New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, NY"},{"name":"Department of Medicine, Columbia University Irving Medical Center, New York, NY"},{"name":"Division of Endocrinology, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2022031310153569700_B1","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"2022031310153569700_B2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2337\/dc06-1549","article-title":"Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes","volume":"30","author":"Laferr\u00e8re","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B3","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jc.2007-2851","article-title":"Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes","volume":"93","author":"Laferr\u00e8re","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031310153569700_B4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/dc16-1376","article-title":"Glucose metabolism after gastric banding and gastric bypass in individuals with type 2 diabetes: weight loss effect","volume":"40","author":"Holter","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B5","doi-asserted-by":"crossref","first-page":"E1372","DOI":"10.1210\/jc.2011-0446","article-title":"The role of \u03b2-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery","volume":"96","author":"Nannipieri","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031310153569700_B6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db13-1176","article-title":"Limited recovery of \u03b2-cell function after gastric bypass despite clinical diabetes remission","volume":"63","author":"Dutia","year":"2014","journal-title":"Diabetes"},{"key":"2022031310153569700_B7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJMoa2003697","article-title":"Effects of diet versus gastric bypass on metabolic function in diabetes","volume":"383","author":"Yoshino","year":"2020","journal-title":"N Engl J Med"},{"key":"2022031310153569700_B8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ijo.2009.254","article-title":"Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes","volume":"34","author":"Kashyap","year":"2010","journal-title":"Int J Obes"},{"key":"2022031310153569700_B9","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1172\/JCI64895","article-title":"Gastric bypass and banding equally improve insulin sensitivity and \u03b2 cell function","volume":"122","author":"Bradley","year":"2012","journal-title":"J Clin Invest"},{"key":"2022031310153569700_B10","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/ajcn\/83.4.809","article-title":"Validation of a 3-dimensional photonic scanner for the measurement of body volumes, dimensions, and percentage body fat","volume":"83","author":"Wang","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"2022031310153569700_B12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11695-020-04905-6","article-title":"Anthropometrics by three-dimensional photonic scanner in patients with obesity before and after bariatric surgery","volume":"31","author":"Shah","year":"2021","journal-title":"Obes Surg"},{"key":"2022031310153569700_B13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/diacare.18.2.245","article-title":"The use of areas under curves in diabetes research","volume":"18","author":"Allison","year":"1995","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2022031310153569700_B15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1172\/JCI115396","article-title":"Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep","volume":"88","author":"Van Cauter","year":"1991","journal-title":"J Clin Invest"},{"key":"2022031310153569700_B16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc18-1036","article-title":"Insulin clearance after oral and intravenous glucose following gastric bypass and gastric banding weight loss","volume":"42","author":"Shah","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B17","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.2337\/db13-0022","article-title":"Exaggerated glucagon-like peptide 1 response is important for improved \u03b2-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes","volume":"62","author":"J\u00f8rgensen","year":"2013","journal-title":"Diabetes"},{"key":"2022031310153569700_B18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.soard.2012.01.021","article-title":"Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss","volume":"8","author":"Pournaras","year":"2012","journal-title":"Surg Obes Relat Dis"},{"key":"2022031310153569700_B19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1126\/science.1235103","article-title":"Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass","volume":"341","author":"Saeidi","year":"2013","journal-title":"Science"},{"key":"2022031310153569700_B20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/gutjnl-2018-317760","article-title":"Beta-cell sensitivity to insulinotropic gut hormones is reduced after gastric bypass surgery","volume":"68","author":"Salehi","year":"2019","journal-title":"Gut"},{"key":"2022031310153569700_B21","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s00125-013-3055-1","article-title":"Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass","volume":"56","author":"Dirksen","year":"2013","journal-title":"Diabetologia"},{"key":"2022031310153569700_B22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2337\/diacare.21.1.2","article-title":"The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes","volume":"21","author":"Williams","year":"1998","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B23","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1381\/0960892041975668","article-title":"Calorie intake and meal patterns up to 4 years after Roux-en-Y gastric bypass surgery","volume":"14","author":"Ward\u00e9-Kamar","year":"2004","journal-title":"Obes Surg"},{"key":"2022031310153569700_B24","first-page":"415","article-title":"Glucose toxicity","volume":"13","author":"Yki-J\u00e4rvinen","year":"1992","journal-title":"Endocr Rev"},{"key":"2022031310153569700_B25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2010.04.009","article-title":"The stunned beta cell: a brief history","volume":"11","author":"Ferrannini","year":"2010","journal-title":"Cell Metab"},{"key":"2022031310153569700_B26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/dom.13165","article-title":"Beta-cell sensitivity to glucose is impaired after gastric bypass surgery","volume":"20","author":"Salehi","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"2022031310153569700_B27","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.2337\/db11-0203","article-title":"Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans","volume":"60","author":"Salehi","year":"2011","journal-title":"Diabetes"},{"key":"2022031310153569700_B28","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.2337\/dc12-1535","article-title":"GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery","volume":"36","author":"Jim\u00e9nez","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B29","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/SLA.0b013e31826b8603","article-title":"GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects","volume":"257","author":"Jim\u00e9nez","year":"2013","journal-title":"Ann Surg"},{"key":"2022031310153569700_B30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/dc15-0575","article-title":"Determinants of diabetes remission and glycemic control after bariatric surgery","volume":"39","author":"Panunzi","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B31","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.2337\/dc20-0157","article-title":"Comparison of preoperative remission scores and diabetes duration alone as predictors of durable type 2 diabetes remission and risk of diabetes complications after bariatric surgery: a post hoc analysis of participants from the Swedish Obese Subjects Study","volume":"43","author":"Sj\u00f6holm","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B32","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1007\/s00125-017-4371-7","article-title":"The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass","volume":"60","author":"Aron-Wisnewsky","year":"2017","journal-title":"Diabetologia"},{"key":"2022031310153569700_B33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S2213-8587(13)70070-6","article-title":"Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study","volume":"2","author":"Still","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031310153569700_B34","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.2337\/dc21-0395","article-title":"Pre-intervention clinical determinants and measured \u03b2-cell function as predictors of type 2 diabetes remission after Roux-en-Y gastric bypass surgery","volume":"44","author":"Ligon","year":"2021","journal-title":"Diabetes Care"},{"key":"2022031310153569700_B35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11695-012-0802-1","article-title":"A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass","volume":"23","author":"Arterburn","year":"2013","journal-title":"Obes Surg"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/2\/469\/642517\/dc211270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/2\/469\/642517\/dc211270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T11:25:02Z","timestamp":1647170702000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/45\/2\/469\/139003\/Role-of-the-Gut-in-the-Temporal-Changes-of-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc21-1270","relation":{},"ISSN":["0149-5992"],"issn-type":[{"value":"0149-5992","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}